ISEC Healthcare has reported earnings of $3.2 million for its 1QFY2024, down 6% y-o-y, no thanks to heftier administrative costs.
Revenue in the same period remained the same at $16.9 million.
On one hand, revenue from its general health services was down by $170,000, due to reduced volume from pandemic-related services such as swab tests.
On the other hand, revenue from its specialised health services revenue increased by $170,000 to $16.02 million, with growth driven by a bigger number of procedures performed in Malaysia.
ISEC Healthcare shares last changed hands at 39 cents, down 18.09% year to date.
